In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dexo Brand of Amfepramone Hydrochloride Drug Master File in Korea (Dexo Brand of Amfepramone Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dexo Brand of Amfepramone Hydrochloride. The MFDS reviews the Dexo Brand of Amfepramone Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Dexo Brand of Amfepramone Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dexo Brand of Amfepramone Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dexo Brand of Amfepramone Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dexo Brand of Amfepramone Hydrochloride suppliers with KDMF on PharmaCompass.